Infliximab for chronic obstructive pulmonary disease: Towards a more specific inflammation targeting?

Expert Opinion on Investigational Drugs

Volumn 15, Issue 2, 2006, Pages 181-184

  Antoniu, Sabina A ^a,b  

^a Clinic of Pulmonary Disease   (Romania)

^b NONE   (Romania)

Author keywords

COPD; eNO; Infliximab; TNF

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; INFLIXIMAB; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY TITER; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COUGHING; CROHN DISEASE; DISEASE EXACERBATION; DRUG CLEARANCE; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; DRUG WITHDRAWAL; FLU LIKE SYNDROME; HUMAN; INFECTION; MACROPHAGE; NEUTROPHIL; PATHOGENESIS; RHEUMATOID ARTHRITIS; SHORT COURSE THERAPY; SIDE EFFECT; SMOKING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; DRUG DELIVERY SYSTEMS; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 32844471816     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.15.2.181     Document Type: Article

References (9)

1. KEATINGS VM, COLLINS PD, SCOTT DM, BARNES PJ: Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. (1996) 153(2):530-534.
2. TAYLOR PC, WILLIAMS RO, FELDMANN M: Tumour necrosis factor α as a therapeutic target for immune-mediated inflammatory diseases. Curr. Opin. Biotechnol. (2004) 15(6):557-563.
3. DE GODOY I, DONAHOE M, CALHOUN WJ, MANCINO J, ROGERS RM: Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. Am. J. Respir. Crit. Care Med. (1996) 153(2):633-637.
4. VAN DER VAART H, KOETER GH, POSTMA DS, KAUFFMAN HF, TEN HACKEN NH: First study of infliximab treatment in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. (2005) 172(4):465-469.
5. ARNOTT ID, McNEILL G, SATSANGI J: An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease. Aliment. Pharmacol. Ther. (2003) 17(12):1451-1457.
6. PELEMAN RA, RYTILA PH, KIPS JC, JOOS GF, PAUWELS RA: The cellular composition of induced sputum in chronic obstructive pulmonary disease. Eur. Respir. J. (1999) 13(4):839-843.
7. KEATINGS VM, BARNES PJ: Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am. J. Respir. Crit. Care Med. (1997) 155(2):449-453.
8. KHARITONOV SA, BARNES PJ: Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease. Proc Am. Thorac. Soc. (2004) 1(3):191-199.
9. BARNES PJ: Chronic obstructive pulmonary disease * 12: new treatments for COPD. Thorax (2003) 58(9):803-808.